- Healthcare Triangle, Inc. (HCTI) has signed a non-binding Letter of Intent (LOI) to acquire **Teyame.AI LLC**, a Spain-based leader in AI-powered omnichannel customer experience solutions.  **[1839285_20251009SF93338:0]** 
- This acquisition is projected to add approximately **$34 million in incremental annual revenue** and **$4.2 million in incremental EBITDA** for HCTI in fiscal year 2025.  **[1839285_20251009SF93338:0]** 
- The strategic move aims to position HCTI as a global force in AI-powered customer and patient engagement, expanding its international market reach and integrating Teyame's advanced AI automation platform with HCTI's healthcare technology expertise.  **[1839285_20251009SF93338:0]** **[1839285_20251009SF93338:1]**

Healthcare Triangle Signs LOI to Acquire Teyame.AI, Boosting AI Capabilities and Expected 2025 Revenue

- Healthcare Triangle, Inc. (HCTI) has entered into agreements with certain existing accredited and institutional investors for the immediate exercise of **377,702** outstanding warrants.  **[1839285_20251003NY90188:0]** 
- The exercise price of these existing warrants was reduced from **$20.92** to **$2.00** per share.  **[1839285_20251003NY90188:0]** 
- This transaction is expected to generate approximately **$755,000** in gross cash proceeds for HCTI.  **[1839285_20251003NY90188:0]** 
- In consideration for the exercise, investors will receive new unregistered warrants to purchase up to an aggregate of **377,702** shares of common stock at an exercise price of **$3.00** per share.  **[1839285_20251003NY90188:0]** 
- The closing of this warrant inducement is anticipated to occur on or about **October 6, 2025**.  **[1839285_20251003NY90188:0]**

Healthcare Triangle announces warrant inducement transaction

- Healthcare Triangle, Inc. (HCTI) is raising approximately **$1.63 million** in gross cash proceeds through warrant exercise agreements with three existing accredited investors.  **[1839285_20251002NY89400:0]** 
- To induce the immediate exercise of **812,775** outstanding warrants, HCTI reduced their exercise price from **$20.92 to $2.00 per share**.  **[1839285_20251002NY89400:0]** 
- In consideration, the investors will receive new unregistered warrants to purchase an additional **812,775** shares of common stock at an exercise price of **$3.00 per share**, exercisable upon stockholder approval and expiring in five years.  **[1839285_20251002NY89400:0]** 
- This transaction is expected to close on **October 2, 2025**.  **[1839285_20251002NY89400:0]**

Healthcare Triangle Announces Warrant Inducement Transaction

- Healthcare Triangle's (HCTI) subsidiary, QuantumNexis, announced its Ezovion Electronic Medical Record (EMR) platform has processed over **$20 million in revenue** generated by healthcare providers.  **[1839285_20251001SF87703:0]** 
- The total revenue processed through the Ezovion platform by end users is **projected to surge to $37 million** over the next six months, driven by rapid global expansion.  **[1839285_20251001SF87703:0]** 
- QuantumNexis will launch a proprietary integrated payment gateway, enabling it to directly monetize transactions by earning **0.05%** of all revenue processed through the platform.  **[1839285_20251001SF87703:0]** 
- Initial deployments of the payment gateway are planned for **late 2025**, with comprehensive global scaling expected throughout 2026.  **[1839285_20251001SF87703:0]**

Healthcare Triangle's QuantumNexis Processes $20M in Revenue, Projects Growth to $37M, and Plans Payment Gateway Launch

- Healthcare Triangle, Inc. **regained compliance** with Nasdaq Listing Rule 5635(a)(1) on **September 15, 2025**, after amending an acquisition agreement that previously lacked shareholder approval.  **[1839285_0001213900-25-087694_ea0257453-8k_healthcare.htm:1]** 
- The company projects approximately **$20 million** in potential revenue for **2025**, supported by **$15.8 million** in committed backlog and **$2 million** in year-to-date wins.  **[1839285_0001213900-25-087694_ea025745301ex99-1_healthcare.htm:0]** **[1839285_0001213900-25-087694_ea025745301ex99-1_healthcare.htm:2]** 
- HCTI is strategically positioned in high-growth healthcare technology markets, including EHR, Cloud, and AI, targeting gross margins of **30% to 70%+**.  **[1839285_0001213900-25-087694_ea025745301ex99-1_healthcare.htm:0]** **[1839285_0001213900-25-087694_ea025745301ex99-1_healthcare.htm:1]** 
- **Sujatha Ramesh** was appointed Chief Operating Officer in **March 2025**, and **David Ayanoglou** was appointed Chief Financial Officer in **April 2025**.  **[1839285_0001213900-25-087694_ea025745301ex99-1_healthcare.htm:2]**

Healthcare Triangle (HCTI)